Vishnu Chemicals - Is Growth sustainable?

[Chandragupta]

Yes, it will help in margin expansion. But not immediately, it may take 6 months to a year for the mine to become operational and supplies to begin. But once that happens, Vishnu will save on producer margins plus margins made by dealers and other intermediaries in the supply chain. Besides that, it will also give Vishnu better operational control over its key raw material, aid production planning and bring down RM hedging & inventory costs. Supply from a single mine source will also help improve output yields and better realizations. The mine ensures at least a 30-year supply of raw material to Vishnu. With this acquisition, the company claims they will become the lowest cost producer of chromium chemicals in the world.

(Disc.: Holding)

[Folok]

VCL stands out with strong internal tailwinds — Improving margins from backward integration (Chrome mining complex) + New product introductions (DMSO, Chrome metal, Strontium Carbonate etc. which qualify for import substitution) + 15-20% expected growth in margin accretive Barium Chemicals segment + Capacity expansion for its existing products (Chrome Oxide Green).

All this combined with decent valuations makes VCL a compelling case for closer scrutiny.

Financials

The Co’s revenue had grown at a fast clip except during FY24, when Chromium sales plunged 17% y-o-y, due to declining price realizations, softened export demand and increased chrome ore prices which the Co could only partially pass on.

During the same time, the Barium segment’s share as a % of revenue increased as well. This trend is expected to increase and is positive for the company as the Barium segment boasts higher gross margins in comparison to the Chromium segment.

Historically, EBITDA margins have been steady around ~16%.

We don’t endorse the FY26 and FY27 estimates of 18% EBITDA margin provided by Emkay Research. As of H2 FY26, EBITDA margins were ~15.2%. For our forward projections, we will consider the EBITDA margins to increase at a more conservative pace.

Debt funded Capex

As of Nov 2025, consolidated debt stood at ₹450 crore.

Source: Care Edge credit rating (Nov 2025)

However, the same is expected to increase as the company is undertaking a ₹320 crore capex for setting up a DMSO plant and a new chrome oxide green production line, funded through ₹240 crore term debt and ₹80 crore internal accruals.

Source: Care Edge credit rating (Nov 2025)

This action will impact the Co’s:

1. Debt levels and finance costs
2. Depreciation expenses
3. Higher capex leading to lesser FCFs

Apart from non-fund-based limits (LCs, BGs etc.), the Co’s debt is divided into two parts — working capital and term loans. As per the Co’s most recent rating report, the average utilization of working capital limits stood at ~81% for 12 months ended August 2025. The limit being at 162 Crs.

Based on the same, we can infer the remaining term debt at ₹320 Cr. Add to the same ₹240 Cr of term debt owing to the new facility, total consolidated debt would stand at ₹560 Cr. Based on VCL’s current interest rate of 9.25% (from FY25 AR), the incremental debt would lead to an additional interest outflow of ₹22 Crs.

Depreciation expenses would not surge as much because the capex would be in the form of Capital Work-in-Progress (CWIP) in the first 1-2 years. CWIP means that it is not available for use ; it is still being constructed or installed. Therefore, no depreciation is charged on CWIP. Hence, depreciation would only meaningfully increase from FY28 onwards.

Working Capital

The commentary from Emkay Research is satisfactory. However, working capital intensity is likely to trend downward. Erstwhile, VCL imported 100% of its chrome ore requirements and maintained higher raw-material inventory to ensure uninterrupted production.

The acquisition of the chrome ore mine is aimed at mitigating the impact of chrome ore price volatility on profitability margins and moderate inventory holding levels.

Of the total reserves in the mine, ~4,00,000 tonnes are open-accessible, sufficient to meet VCL’s requirements for ~2.5–3 years. With further expansion, VCL estimates the life of the reserve at 30 years.

[Folok]

Before discussing valuations, it is imperative to discuss risks:

1. Raw Material Risk: Key raw materials used in manufacturing chromium and barium products include chrome ore, soda ash, and barytes, which are subject to price volatility. A large share of the RM is sourced domestically & internationally despite meaningful backward integration in the soda ash and mining complex acquisition.Although VCL generally has the pricing power to pass on cost increases to customers, this ability is dependent on prevailing demand conditions and product realizations. Any sudden spike in global raw material prices, freight costs etc. due to supply disruptions or geopolitical constraints can impact gross margins.
2. Execution risk in various forward-looking initiatives. Delays in execution, cost overruns or failure to scale as expected could affect Vishnu’s growth trajectory and returns on capital employed.
3. Demand slowdown in end-use applications: Demand slowdown in end user applications like pharmaceuticals, electroplating, master batches, refractories, wood preservatives, ceramics, and paints, at any point in time, can potentially drag volumes/pricing. However, the impact is moderated due to applications across a range of industries.

Valuations

Our take on valuations is simple: when a company which has positive optionalities in the near term is trading cheap even at base case projections, we sit up and take interest.

We had already summarized the positive optionalities at the very beginning. A snapshot of the same:

Based on the same, the following is our P&L projections. Based on FY27 earnings, the 1-year forward PE would be around ~19x.

Conservatively, we also estimate the intrinsic value of the firm at ~₹2400 Crs against the current market cap of ~₹3400 Cr imputing a downside of -29%. That is if the stock were to fall 29% from current prices, we would evaluate it seriously — provided our current assumptions hold.

If you’re not familiar with the line of reasoning we used to value the Co, check out this article here.

Final Thoughts

As of date, I do not hold any position in VCL. Almost every box checks out for the Co, except for the valuation .

[Prabhat_Mohanty]

I think your valuation regarding its intrinsic value is very conservative. It is a bearish situation valuation without consideration of growth potential. With PAT growing in 22-25 percent and EBITDA @ more than 30 percent, rising ROE, one would expect higher PE.
I would like to know your stock holdings and their rationale. I am sure you will not find many companies worth investing with your logic. Conversely it is a very good tool as margin of safety.
My views may be taken as a biased one as I am presently invested and consider it as a buy on dip stock.

[vikasbargale]

Just sharing a YouTube video on Vishnu Chemicals by Ajay Joshi

Also below is the youtube link for the latest AGM

Invested with just 2% allocation.

[hitesh97]

Does Q2 FY26 concall happen? I couldn’t find transcript of the same.

[ucmsuri]

Looks like they are not consistent with concalls.

[ucmsuri]

One thing that is bit unclear for me is despite being in one of the few companies worldwide in this specialty space, they are not having the pricing power of their competitors. The reason may be mainly due to the following?

1. their manufacturing not present globally, exports eating up some margins.
2. Product breadth (basic) and depth (specialized)
3. Volume vs value oriented products

Was just trying to understand why is their EBIDTA low compared to the global competitors using AI in the attached doc. So take the data with pinch of salt.

vishnu_chemicals_analysis.docx (182.6 KB)

[Chandragupta]

These are diversified chemical players and their margins cannot be compared to Vishnu. We will not know how much margins they are making from Chromium or Barium alone. And anyway, since these are commodity products, we should not assume any pricing power at all with anyone. What is positive for Vishnu is their low cost advantage Vs. European players and they provide higher supply chain reliability to their Indian customers Vs. alternative being to import.

[Aswin_MM]

Hi everyone,

I’ve been reading through this thread (great insights from seniors dating back to 2015) and wanted to share my latest detailed analysis on where Vishnu Chemicals stands today.

While the company has historically been viewed as a cyclical commodity converter, I believe we are currently at a structural inflection point driven by two specific triggers: Backward Integration (SA Mine) and Value Addition (Strontium/Pharma).

Here is my thesis on why the risk-reward seems favorable at current valuations (~₹520 levels), along with some forward estimates for FY27. I would love to hear your thoughts and counter-views on this.

1. The Core Thesis: Structural Margin Expansion

The biggest overhang on Vishnu has always been raw material volatility (Chrome Ore). The acquisition of the mine in South Africa (expected completion Jan 2026) fundamentally changes the operating model.

• The Math: Previously, they bought ore at market prices (~$300/ton). Owning the mine implies sourcing at cost (~$100-110/ton + Logistics).
• Impact: Even after accounting for logistics (Richards Bay → Vizag), I estimate a structural EBITDA margin expansion of 200-300 bps starting FY27. This moves the reliable margin floor from ~15% to ~18%.

2. The “Hidden” Trigger: Strontium Carbonate

Most of the street is focused on Chromium, but the Strontium pivot (Jayanshree acquisition) is the key to de-cyclicality.

• Import Substitution: India imports 100% of its Strontium Carbonate (mostly for Ferrite Magnets/EVs). Vishnu’s new capacity (commissioned Aug 2025) aims to capture this domestic demand.
• Valuation Angle: This moves the revenue mix slightly away from the cyclical Leather/Construction segments towards EV/Auto-ancillaries.

3. Financial Check: FY25 Actuals vs. Narrative

Looking at the audited FY25 numbers, the recovery is visible even before the mine benefit kicks in:

• Sales: ₹1,447 Cr (Volume growth returned after the FY24 destocking).
• EBITDA Margin: ~15.9% (Resilient despite freight headwinds).
• PAT: ~₹127 Cr.

The fact that they defended ~16% margins without the mine gives me confidence in the 18%+ guidance for FY27.

4. Valuation & Scenario Analysis (FY27E)

I have modeled the potential earnings for FY27 (first full year of mine integration + Strontium ramp-up).

Base Case Assumptions:

• Revenue Growth: ~12-14% CAGR (Volume led).
• EBITDA Margins: 17.5% (Conservative estimate post-integration).
• PAT: ~₹190 - ₹200 Cr.

At the current market cap of ~₹3,500 Cr, we are effectively paying ~17-19x FY27 Earnings. If the “Specialty Chemical” narrative plays out and the market re-rates this to 25-28x, there is significant room for upside. The downside seems capped given the historical valuation floor of 18-20x for this sector.

5. Key Risks (The Anti-Thesis)

I am tracking these specific red flags:

1. Transnet Logistics: South African rail infrastructure is notoriously unreliable. Reliance on trucking could eat into the projected cost savings of the mine.
2. EU Anti-Dumping on Barium: The ongoing investigation is a risk to the export volumes of the Barium segment (~15% of rev).
3. Execution Lag: Restarting a mine under “Care & Maintenance” often takes longer than management guidance.

Questions for the Community:

1. Has anyone tracked the real-time freight rates from Richards Bay to Vizag recently?
2. For those tracking since 2015, how do you rate the management’s execution on previous large capex cycles (like the Hyderabad to Vizag shift)? Do they generally deliver on timeline guidance?

Discl: Analysing. My views are biased. Not a SEBI reg. advisor.

[Snowman]

[ucmsuri]

I think we should watch for growth in the topline % mix of strontium (import substitute) > barium > chromium (both the back integration and making more specialized versions that will have more pricing power)

[Hrudit_Shah]

A possible anti-thesis to what otherwise looks like a solid integrated specialty player with great new products in Strontium Carbonate and Chrome metal.

1)The declining margins in their chromium chemicals business (I have equated their standalone business to be their chromium business.)

I can not get over the consistent decline in their chromium business EBITDA margins. It was explained in the Q4 FY 24 concall that FY 24 that there was a significant pricing pressure “So, which means that the whole revenue dip that I see of about plus 20% is too purely do with the realization.” which could have led to the reduced margins.

I was tempted to chalk this off to rising chromite prices which would effectively be taken care of with the SA mine acquisition. However, chrome ore prices have not seen a correlated upturn that should squeeze the margin in this manner.

https://www.bigmint.co/intel/detail/india-base-prices-rise-2-m-o-m-at-omc-s-chrome-ore-auction-34607

I am worried this is more of a structural supply side issue with abundant supply at fault rather than a problem with rising chromite prices. Sisecams recent commentary on the chromium Industry also indicated the same: “The global chromium chemicals market remained subdued, largely due to declining demand across nearly all sectors
and geographies particularly in India, China and Brazil, compounded by ongoing tariff-related tensions” Page 10 of this quarters earnings report https://www.sisecam.com/en/s-investor-relations/Documents/Bulletins/Sisecam%20Q3%202025%20Earnings%20Release.pdf.

Keeping in mind that 72-75% of Vishnus revenue comes from chromium where the supply side in terms of exports might not be as favorable as assumed spooked me.

2. This is more of a question from my side than a conjecture: Barium chemicals margins seem to be driven by PBS. Barium carbonate is considered to be a commodity chemical and EBITDA margins are likely in the 10-11% range rather than the 20-25% range exhibited by the overall barium chemicals segment. I do understand that margins in PBS are solid in India where Vishnu is preffered over Chinese suppliers and sales are largely driven by Import substitution but having served 30-40% of the Indian market domestically how much room is there to grow in PBS? With massive Chinese capacities for Barium chemicals and China having 70% of global PBS market share will Vishnu be able to compete globally and maintain these margins? Maybe I have the wrong assessment of the market so please correct me if thats the case.

3. A definite positive in every investors mind was Vishnu getting into Chrome metal manufacturing which has 2 KTPA demand in India but is completely imported at the moment. They had guided for an FY 26 launch.
   FY 23 Q4 concall: “chromium metal like as I mentioned the R&D activity is going on and it is very advanced stage and we are hoping to start looking at a pilot plant somewhere towards end of this year”
   FY 24 Q4 concall: “Well, the chromium metal project, it’s progressing well. We have done some pilot work at our R&D plant and we’re looking at launching this product towards early next year”

However in FY 25 Q4 call there was a significant tone change and it does not seem the chrome metal project is still as imminent as assumed: “While chrome metal, it remains our long-term strategy. At present, we focus in on commissioning strontium carbonate project. Once that is on track, we will revisit the chrome metal with clear road map because there are better opportunities out there. This could be done by us or in a partnership.So we are still considering the way forward. So we are looking at more on a medium- to longterm perspective. But this is definitely on cards, and we are – we continue to work on this, keeping in mind that market demand and capital allocation, we should maintain some discipline for that”

Q1 FY 26 call:“I think that is going to further improve our cost position in terms of the Chrome metal plan what we have also will play a significant role with the kind of product mix, what we are going to look at.”

The latest credit report has mentioned additional capacity coming up for “chrome oxide green (COG), expected to be commercialized by end of Q3FY27 and Q4FY27 respectively.” Seeing as COG is the main precursor for making chrome steel probably the project is on track and I am being paranoid.

Having said all of this they are going to become a fully integrated player in Chrome, have solid margins in the Barium chemicals and Strontium Carbonate is poised to do great given it is completely imported and is used in the hot sectors of EVs, electronics and ferrite magnets.

I am very new to investing and might be focusing on irrelevant/minute details that could be putting me off from making an investment (in general and possibly in this company) so please do tell me if you feel that is the case!

[vikasbargale]

Great in depth write up. My sincere suggestion- take an initial exposure of maybe one or two % and then see how it goes from here. This way you will avoid the FOMO.
Invested and biased with 4% allocation.

[Aswin_MM]

Since taxation is made 0% in EU India trade deal for exports from India to EU how will this affect Vishnu chemicals. As far as I know their chromium business has moderate exposure to EU whereas barium has high exposure to EU and 68% of their exports of Barium is to EU.

Please let me know your thoughts